$149 Million is the total value of Foresite Capital Opportunity Management V, LLC's 9 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | Pardes Biosciences Inc | $85,571,000 | – | 5,227,307 | +100.0% | 57.37% | – | |
| New | Cue Health Inc. | $20,478,000 | – | 1,527,103 | +100.0% | 13.73% | – | |
| QSI | New | Quantum-Si Incorporated | $12,577,000 | – | 1,598,125 | +100.0% | 8.43% | – |
| GMTX | New | Gemini Therapeutics, Inc. | $7,086,000 | – | 2,435,125 | +100.0% | 4.75% | – |
| New | Theseus Pharmaceuticals, Inc. | $5,945,000 | – | 468,820 | +100.0% | 3.99% | – | |
| CGEM | New | Cullinan Oncology, Inc. | $5,879,000 | – | 381,002 | +100.0% | 3.94% | – |
| KNTE | New | Kinnate Biopharma Inc. | $5,168,000 | – | 291,667 | +100.0% | 3.46% | – |
| CMPX | New | Compass Therapeutics, Inc. | $3,487,000 | – | 1,100,000 | +100.0% | 2.34% | – |
| ACET | New | Adicet Bio, Inc. | $2,973,000 | – | 170,000 | +100.0% | 1.99% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Pardes Biosciences Inc | 4 | Q3 2022 | 57.4% |
| Theseus Pharmaceuticals, Inc. | 4 | Q3 2022 | 16.7% |
| Gemini Therapeutics, Inc. | 4 | Q3 2022 | 12.0% |
| Quantum-Si Incorporated | 4 | Q3 2022 | 10.5% |
| Kinnate Biopharma Inc. | 4 | Q3 2022 | 10.5% |
| Compass Therapeutics, Inc. | 4 | Q3 2022 | 10.6% |
| Adicet Bio, Inc. | 4 | Q3 2022 | 7.3% |
| Enanta Pharmaceuticals, Inc. | 3 | Q3 2022 | 3.5% |
| Cue Health Inc. | 2 | Q1 2022 | 13.7% |
| Cullinan Oncology, Inc. | 2 | Q1 2022 | 4.8% |
View Foresite Capital Opportunity Management V, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-05 |
| 4 | 2023-08-31 |
| 4 | 2023-07-19 |
| 4 | 2023-05-10 |
| 4 | 2023-04-06 |
| 4 | 2023-02-22 |
| 4 | 2023-01-03 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 3 | 2022-06-13 |
View Foresite Capital Opportunity Management V, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.